Scientific article
English

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

Published in

The Journal of infectious diseases, vol. 155, no. 2, p. 187-191

Publication date

1987

Abstract

In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 200 mg/day intravenously or intramuscularly) was compared with flucloxacillin (8 g/day) in patients with severe staphylococcal infections. Teicoplanin proved unsatisfactory for the following reasons: failures or relapses were more frequent in the teicoplanin group, and blood levels were difficult to predict and tended to be low 24 hr after the loading dose. Future trials with this agent should use much-higher doses.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents/ therapeutic use
  • Clinical Trials as Topic
  • Cloxacillin/ analogs & derivatives
  • Floxacillin/administration & dosage/ therapeutic use
  • Glycopeptides/administration & dosage/blood/therapeutic use
  • Humans
  • Middle Aged
  • Prospective Studies
  • Random Allocation
  • Staphylococcal Infections/ drug therapy
  • Staphylococcus/drug effects
  • Staphylococcus aureus/drug effects
  • Teicoplanin

Citation (ISO format)

CALAIN, Philippe et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. In: The Journal of infectious diseases, 1987, vol. 155, n° 2, p. 187–191. doi: 10.1093/infdis/155.2.187

Main files (1)

Article

Identifiers

Journal ISSN

0022-1899
666views
0downloads

Technical informations

Creation

21/06/2010 10:23:27

First validation

21/06/2010 10:23:27

Update

14/03/2023 15:42:58

Status update

14/03/2023 15:42:57

Last indexation

29/10/2024 15:07:29
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated